Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LNTH
LNTH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LNTH News
Lantheus LNTH-2501 Review Period Extended by FDA
Mar 18 2026
seekingalpha
FDA Extends Review of LNTH-2501 by Three Months
Mar 17 2026
stocktwits
Lantheus Holdings Exceeds 2025 Financial Expectations
Mar 09 2026
Fool
U.S. Stock Futures Lower, Investors Eye Individual Stocks
Mar 09 2026
Benzinga
Lantheus Receives FDA Approval for New Imaging Agent
Mar 07 2026
NASDAQ.COM
Lantheus Holdings' PYLARIFY TruVu Injection Receives FDA Approval
Mar 06 2026
stocktwits
Lantheus Launches New PSMA PET Imaging Agent PYLARIFY TruVu
Mar 06 2026
Newsfilter
Lantheus Holdings Under Investigation for Securities Violations
Mar 02 2026
Businesswire
Lantheus Receives FDA Tentative Approval for New Drug
Mar 02 2026
Newsfilter
Lantheus Holdings Q4 2025 Earnings Call Insights
Feb 27 2026
seekingalpha
Lantheus Holdings Reviews 2025 Performance and Future Outlook
Feb 26 2026
Yahoo Finance
Mixed Earnings Reports Drive Stock Movements
Feb 26 2026
CNBC
Lantheus Reports Strong 2025 Financials, Shifts Focus to Radiodiagnostics
Feb 26 2026
Newsfilter
Lantheus Holdings Set to Announce Q4 Earnings
Feb 25 2026
seekingalpha
Overview of FDA Regulatory Developments
Feb 25 2026
NASDAQ.COM
Lantheus to Host Q4 and Full Year 2025 Financial Results Call
Feb 12 2026
Newsfilter
Show More News
